Germany· DE-A57-96a7aa61b672d12d
Amloator
A medicinal product containing amlodipine, atorvastatin, registered in Germany by Apontis Pharma Deutschland Gmbh & Co. Kg.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Amlodipine, Atorvastatin
- Manufacturer
- Apontis Pharma Deutschland Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amlodipine, atorvastatin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAmlodipine and atorvastatinMylan Pharmaceuticals Inc.
- CzechiaCADUETUpjohn EESV, Capelle aan den IJssel
- CanadaAPO-AMLODIPINE-ATORVASTATINAPOTEX INC
- SpainAMLODIPINO/ATORVASTATINA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKrka D.D. Novo Mesto
- FranceCADUET 10 mg/10 mg, comprimé pelliculéBB FARMA (ITALIE)
- FinlandAmlodipin/Atorvastatin Ratiopharmratiopharm GmbH
- PolandAmlatorGedeon Richter Plc.
- SwitzerlandCaduet
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Atorvalan Comp., Caduet
- Bulgaria · Амлатор, Атордапин
- Czechia · Amlator, Caduet
- Spain · Amlodipino/Atorvastatina Krka, Amlodipino/Atorvastatina Normon
- France · Amlodipine/Atorvastatine Viatris, Caduet
- Croatia · Atordapin, Caduet
- Hungary · Amlator, Caduet
- Lithuania · Atordapin
- Latvia · Atordapin, Caduet
- Poland · Amlator
- Portugal · Caduet, Trinalion
- Romania · Caduet, Lirtonen
- Slovenia · Amaloris, Lirtonen
- Slovakia · Amlator, Dicartil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a045be43-db7d-4dfe-91a1-570d8568d095 GET /v1/drugs/a045be43-db7d-4dfe-91a1-570d8568d095?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Amlodipine, Atorvastatin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about amlodipine, atorvastatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.